Mrs Lori L Whiteman, RPH | |
3250 N Morrison Rd, Muncie, IN 47304-5540 | |
(765) 287-8330 | |
Not Available |
Full Name | Mrs Lori L Whiteman |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 3250 N Morrison Rd, Muncie, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1154604619 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 26018625 (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Lori L Whiteman, RPH 11200 W River Valley Rd, Yorktown, IN 47396-9412 Ph: (765) 215-5293 | Mrs Lori L Whiteman, RPH 3250 N Morrison Rd, Muncie, IN 47304-5540 Ph: (765) 287-8330 |
News Archive
Johns Hopkins University's newly formed Brain Science Institute's NeuroTranslational Program has entered into a licensing agreement with pharmaceutical company Eisai Inc. to discover and develop small molecule glutamate carboxypeptidase II (GCPII) inhibitors.
More than 4,000 children and teens are diagnosed with brain cancer each year and the disease kills more children than any other cancer.
Frailty, a condition that affects 10 percent of people aged 65 and older, can make older adults more prone to disability, falls, hospitalization and a shorter lifespan. Recently, researchers writing in the Journal of the American Geriatrics Society examined the effects of frailty and depression on married couples.
By using data from epidemiological investigations and contact-tracing efforts during the initial phase of the coronavirus disease (COVID-19) epidemic in France, researchers were able to appraise secondary clinical attack rates and factors associated with the risk of a contact becoming a case. Their findings are currently available in a medRxiv preprint paper.
ImmunoCellular Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has given clearance to a physician sponsored investigative new drug (IND) application to initiate a Phase I clinical trial of ICT-121, IMUC's novel dendritic-cell-based vaccine targeting CD-133, an antigen that is highly expressed by multiple solid tumors.
› Verified 7 days ago
Dr. Amber Nicole Kimberlin, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 E Mcgalliard Rd, Muncie, IN 47303 Phone: 765-288-6171 | |
Jubin David, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 E Mcgalliard Rd, Muncie, IN 47303 Phone: 765-288-6171 | |
Dr. Jennifer Marie Mchatton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3645 N Briarwood Ln Ste D, Muncie, IN 47304 Phone: 765-282-4766 | |
Samuel Ryan Balle, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 S Tillotson Ave, Muncie, IN 47304 Phone: 765-287-0074 | |
Mr. Herbert Christopher Halley, RPH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3601 N Barr St, T-1530, Muncie, IN 47303 Phone: 765-254-9084 Fax: 765-254-9084 | |
Todd Jason Jones, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 715 S Tillotson Ave, Muncie, IN 47304 Phone: 765-213-1220 Fax: 765-213-1225 | |
Steven Lee Mcnutt, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2401 W University Ave Fl 5, Muncie, IN 47303 Phone: 765-282-8797 |